Reed Thomas D. 4
4 · INTREXON CORP · Filed Oct 2, 2019
Insider Transaction Report
Form 4
Reed Thomas D.
DirectorChief Science Officer
Transactions
- Exercise/Conversion
Restricted Stock Units
2019-09-30−14,341→ 28,680 total→ Common Stock (14,341 underlying) - Exercise/Conversion
Common Stock
2019-09-30+14,341→ 121,435 total - Sale
Common Stock
2019-10-01$5.50/sh−3,658$20,104→ 117,777 total
Holdings
- 41,705(indirect: By Trust)
Common Stock
- 62,840(indirect: By Trust)
Common Stock
- 2,440(indirect: By Spouse)
Common Stock
Footnotes (5)
- [F1]Each restricted stock unit represents a contingent right to receive one share of XON common stock.
- [F2]This sale was effected pursuant to the terms of a 10b5-1 plan adopted by the reporting person and was made in order to pay the tax liability arising from the vesting of restricted stock units.
- [F3]Held by the Thomas David Reed Living Trust dated February 4, 2011.
- [F4]Held by the Jacquelyn Ann Reed Living Trust dated February 4, 2011.
- [F5]The restricted stock units were granted on April 9, 2019, and the remaining restricted stock units vest in two equal quarterly installments on each of December 31, 2019 and March 31, 2020.